Evidence map›Paper›PMID 42266806›Full record

ArticleJMA journal2026

Artificial Intelligence as a Clinical Co-Pilot in Reminiscence Therapy: A Nurse-Led Model for Super-Aged Societies.

Kazumi Kubota, Yukiko Matsumura

Abstract read
In one paragraph

Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kazumi KubotaResearch Organization, Shimonoseki City University, Shimonoseki, Japan.
Yukiko MatsumuraDepartment of Nursing, Faculty of Nursing, Shimonoseki City University, Yamaguchi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japan's demographic landscape, characterized as a super-aged society, presents an urgent need for scalable psychosocial interventions for dementia and cognitive decline. Reminiscence therapy is an evidence-based non-pharmacological intervention; however, its implementation is often limited by workforce shortages and time constraints. This opinion paper proposes a paradigm shift: utilizing Artificial Intelligence (AI) not as a replacement for caregivers, but as a "clinical co-pilot" under nursing leadership. While generative AI and robotics offer transformative potential to personalize content and extend therapeutic reach, they also introduce risks such as algorithmic bias and "hallucinations" that could distress patients. We argue that successful integration requires a "Human-in-the-Loop" framework in which AI handles data synthesis and engagement monitoring, while healthcare professionals maintain oversight of clinical validity and emotional safety. This approach aims to harmonize technological efficiency with person-centered care, offering a sustainable model for geriatric medicine.

Indexed as

artificial intelligencedementia caregeriatric nursinghuman-in-the-loopreminiscence therapy

Identifiers

PMID42266806
PMCPMC13246264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.